Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-18

Clinical Trial Update: Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years [NA]

View source ↗

Summary

Clinical trial update evaluating caloric restriction and resveratrol effects on the sirtuin system in adults aged 55-65; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: InCor Heart Institute | Conditions: Vascular System Injuries, Lipid Metabolism Disorders | NA | Status: COMPLETED | Results posted: 2016-04-18